High glucose suppresses epidermal growth factor receptor/ phosphatidylinositol 3-kinase/akt signaling pathway and attenuates corneal epithelial wound healing

Diabetes

Volumn 58, Issue 5, 2009, Pages 1077-1085

  Xu, Ke Ping ^a   Li, Yanfeng ^a   Ljubimov, Alexander V ^a   Yu, Fu Shin X ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE; GLUTATHIONE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CORNEA EPITHELIUM; CORNEAL BIOPSY; ENZYME BLOOD LEVEL; ENZYME REPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KERATOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SWINE; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING; WOUND HEALING IMPAIRMENT; ANIMAL; CYTOLOGY; DRUG EFFECT; INJURY; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; EPITHELIUM, CORNEAL; GLUCOSE; GLUTATHIONE; ORGAN CULTURE TECHNIQUES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SWINE; WOUND HEALING;

EID: 65549088833     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0997     Document Type: Article

References (66)

1. Clark CM, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995;332:1210-1217
2. Kaji Y. Prevention of diabetic keratopathy. Br J Ophthalmol 2005;89:254-255
3. Friend J, Ishii Y, Thoft RA. Corneal epithelial changes in diabetic rats.. Ophthalmic Res 1982;14:269-278
4. Taylor HR, Kimsey RA. Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci 1981;20:548-553
5. Azar DT, Spurr MSJ, Tisdale AS, Gipson IK. Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol 1992;110: 537-540
6. McDermott AM, Xiao TL, Kern TS, Murphy CJ. Non-enzymatic glycation in corneas from normal and diabetic donors and its effects on epithelial cell attachment in vitro. Optometry 2003;74:443-452
7. Ljubimov AV, Huang ZS, Huang GH, Burgeson RE, Gullberg D, Miner JH, Ninomiya Y, Sado Y, Kenney MC. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem 1998;46:1033-1042
8. Kabosova A, Kramerov AA, Aoki AM, Murphy G, Zieske JD, Ljubimov AV. Human diabetic corneas preserve wound healing, basement membrane, integrin and MMP-10 differences from normal corneas in organ culture. Exp Eye Res 2003;77:211-217
9. Zagon IS, Sassani JW, McLaughlin PJ. Insulin treatment ameliorates impaired corneal reepithelialization in diabetic rats. Diabetes 2006;55: 1141-1147
10. Wakuta M, Morishige N, Chikama T, Seki K, Nagano T, Nishida T. Delayed wound closure and phenotypic changes in corneal epithelium of the spontaneously diabetic Goto-Kakizaki rat. Invest Ophthalmol Vis Sci 2007;48:590-596
11. Inoue K, Okugawa K, Amano S, Oshika T, Takamura E, Egami F, Umizu G, Aikawa K, Kato S. Blinking and superficial punctate keratopathy in patients with diabetes mellitus. Eye 2005;19:418-421
12. Rehany U, Ishii Y, Lahav M, Rumelt S. Ultrastructural changes in corneas of diabetic patients: an electron-microscopy study. Cornea 2000;19:534-538
13. Saini J, Khandalavla B. Corneal epithelial fragility in diabetes mellitus. Can J Ophthalmol 1995;30:142-146
14. Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy.. Trans Am Ophthalmol Soc 1981;79:180-199
15. Schulze SD, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol 2006;142:207-211
16. Cavallerano J. Ocular manifestations of diabetes mellitus. Optom Clin 1992;2:93-116
17. Tavakoli M, Kallinikos PA, Efron N, Boulton AJ, Malik RA. Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes. Diabetes Care 2007;30:1895-1897
18. Midena E, Brugin E, Ghirlando A, Sommavilla M, Avogaro A. Corneal diabetic neuropathy: a confocal microscopy study. J Refract Surg 2006;22: S1047-S1052
19. Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, Holcmann M. The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 2007;75:770-787
20. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z, Derynck R. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 1995;376:337-341
21. Shah NT, Kris MG, Pao W, Tyson LB, Pizzo BM, Heinemann M-H, Ben-Porat L, Sachs DL, Heelan RT, Miller VA. Practical management of patients with non-small-cell lung cancer treated with gefitinib. J Clin Oncol 2005;23:165-174
22. Specenier P, Koppen C, Vermorken JB. Diffuse punctate keratitis in a patient treated with cetuximab as monotherapy. Ann Oncol 2007;18:961-962
23. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism.. Diabetes 2005;54:1615-1625
24. Kanwar M, Chan PS, Kern TS, Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 2007;48:3805-3811
25. Hallberg CK, Trocme SD, Ansari NH. Acceleration of corneal wound healing in diabetic rats by the antioxidant trolox. Res Commun Mol Pathol Pharmacol 1996;93:3-12
26. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006;212:167-178
27. Whiteside CI. Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species. Curr Hypertens Rep 2005;7:148-154
28. Sato E, Mori F, Igarashi S, Abiko T, Takeda M, Ishiko S, Yoshida A. Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy. Diabetes Care 2001;24:479-482
29. Xu KP, Ding Y, Ling J, Dong Z, Yu FS. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest Ophthalmol Vis Sci 2004;45:813-820
30. Araki-Sasaki K, Ohashi Y, Sasabe T, Hayashi K, Watanabe H, Tano Y, Handa H. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci 1995;36:614-621
31. Foreman DM, Pancholi S, Jarvis-Evans J, McLeod D, Boulton ME. A simple organ culture model for assessing the effects of growth factors on corneal re-epithelialization. Exp Eye Res 1996;62:555-564
32. Xu KP, Yin J, Yu FS. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor. Invest Ophthalmol Vis Sci 2007;48:636-643
33. Akazawa S. Diabetic embryopathy: studies using a rat embryo culture system and an animal model. Congenit Anom (Kyoto) 2005;45:73-79
34. Xu KP, Riggs A, Ding Y, Yu FS. Role of ErbB2 in corneal epithelial wound healing. Invest Ophthalmol Vis Sci 2004;45:4277-4283
35. Marchetti V, Menghini R, Rizza S, Vivanti A, Feccia T, Lauro D, Fukamizu A, Lauro R, Federici M. Benfotiamine counteracts glucose toxicity ffects on endothelial progenitor cell differentiation via Akt/FoxO signaling.Diabetes 2006;55:2231-2237
36. Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH, Liu PL, Chen YL, Chen JW: High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 56:1559-1568, 2007
37. Chikama T, Wakuta M, Liu Y, Nishida T. Deviated mechanism of wound healing in diabetic corneas.. Cornea 2007;26:S75-S81
38. Datiles MB, Kador PF, Fukui HN, Hu TS, Kinoshita JH. Corneal reepithelialization in galactosemic rats. Invest Ophthalmol Vis Sci 1983;24: 563-569
39. Fujita H, Morita I, Takase H, Ohno-Matsui K, Mochizuki M. Prolonged exposure to high glucose impaired cellular behavior of normal human corneal epithelial cells. Curr Eye Res 2003;27:197-203
40. McDermott AM, Kern TS, Murphy CJ. The effect of elevated extracellular glucose on migration, adhesion and proliferation of SV40 transformed human corneal epithelial cells. Curr Eye Res 1998;17:924-932
41. Lu W, Ebihara N, Miyazaki K, Murakami A. Reduced expression of laminin-5 in corneal epithelial cells under high glucose condition. Cornea 2006;25:61-67
42. Takahashi H, Akiba K, Noguchi T, Ohmura T, Takahashi R, Ezure Y, Ohara K, Zieske JD. Matrix metalloproteinase activity is enhanced during corneal wound repair in high glucose condition. Curr Eye Res 2000;21:608-615
43. Zagon IS, Klocek MS, Sassani JW, McLaughlin PJ. Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus. Arch Ophthalmol 2007;125:1082-1088
44. Yucel I, Yucel G, Akar Y, Demir N, Gurbuz N, Aslan M. Transmission electron microscopy and autofluorescence findings in the cornea of diabetic rats treated with aminoguanidine. Can J Ophthalmol 2006;41:60-66
45. Gareskog M, Cederberg J, Eriksson UJ, Wentzel P. Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos. Reprod Toxicol 2007;23:63-74
46. Argirova MD, Argirov OK. Region-specific pathophysiological alterations occurring in calf lenses in vitro during hyperglycemia. Graefes Arch Clin Exp Ophthalmol 2002;240:126-130
47. Arai KY, Nishiyama T. Developmental changes in extracellular matrix messenger RNAs in the mouse placenta during the second half of pregnancy: possible factors involved in the regulation ofplacental extracellular matrix expression. Biol Reprod 2007;77:923-933
48. Zagon IS, Jenkins JB, Sassani JW, Wylie JD, Ruth TB, Fry JL, Lang CM, McLaughlin PJ. Naltrexone, an opioid antagonist, facilitates reepithelial- ization of the cornea in diabetic rat. Diabetes 2002;51:3055-3062
49. Nakamura M, Kawahara M, Morishige N, Chikama T, Nakata K, Nishida T. Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulinlike growth factor-1. Diabetologia 2003;46:839-842
50. Chua BH, Chua CC, Zhao ZY, Krebs CJ. Estrone modulates the EGF receptor in the liver of db/db mouse. J Recept Res 1991;11:941-957
51. Wassef L, Kelly DJ, Gilbert RE. Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes. Kidney Int 2004;66:1805-1814
52. Wu D, Peng F, Zhang B, Ingram AJ, Gao B, Krepinsky JC. Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells. Diabetologia 2007;50:2008-2018
53. Song P, Wu Y, Xu J, Xie Z, Dong Y, Zhang M, Zou MH. Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner. Circulation 2007;116:1585-1595
54. Ho FM, Lin WW, Chen BC, Chao CM, Yang CR, Lin LY, Lai CC, Liu SH, Liau CS. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell Signal 2006;18:391-399
55. Zdychova J, Komers R. Emerging role of Akt kinase/protein kinase B signaling in pathophysiology ofdiabetes and its complications. Physiol Res 2005;54:1-16
56. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007;129:1261-1274
57. Pflugfelder SC. Is autologous serum a tonic for the ailing corneal epithelium? Am J Ophthalmol 2006;142:316-317
58. Lassen N, Bateman JB, Estey T, Kuszak JR, Nees DW, Piatigorsky J, Duester G, Day BJ, Huang J, Hines LM, Vasiliou V. Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice. J Biol Chem 2007;282:25668-25676
59. Lassen N, Black WJ, Estey T, Vasiliou V. The role of corneal crystallins in the cellular defense mechanisms against oxidative stress. Semin Cell Dev Biol 2008;19:100-112
60. Guo J, Sax C, Piatigorsky J, Yu F. Heterogeneous expression of transke- tolase ocular tissues. Curr Eye Res 1997;16:467-474
61. Sax C, Salamon C, Kays W, Guo J, Yu F, Cuthbertson R, Piatigorsky J. Transketolase is a major protein in the mouse cornea. J Biol Chem 1996;271:33568-33574
62. Estey T, Piatigorsky J, Lassen N, Vasiliou V. ALDH3A1: a corneal crystallin with diverse functions. Exp Eye Res 2007;84:3-12
63. el-Remessy AB, Bartoli M, Platt DH, Fulton D, Caldwell RB. Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI3-kinase tyrosine nitration. J Cell Sci 2005;118:243-252
64. Zhang J, Liu Z, Rasschaert J, Blero D, Deneubourg L, Schurmans S, Erneux C, Pesesse X. SHIP2 controls PtdIns(3,4,5)P(3) levels and PKB activity in response to oxidative stress. Cell Signal 2007;19:2194-2200
65. Hori K, Sotozono C, Hamuro J, Yamasaki K, Kimura Y, Ozeki M, Tabata Y, Kinoshita S. Controlled-release ofepidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing. J Controlled Rel 2007;118:169-176
66. Gonul B, Koz M, Ersoz G, Kaplan B. Effect of EGF on the corneal wound healing of alloxan diabetic mice. Exp Eye Res 1992;54:519-524